Now that we have three immunomodulators to choose between, it has become incredibly complex. So many numbers. Many much numbers. And it is not just three times as many things to keep track of, it is exponentially greater. You know, not “three times” but “to the third degree.” Cubed. I am pretty sure that is algebra.
Whoa.
Anyway, anyone who thought the addition of Cequa (cyclosporine ophthalmic solution 0.09%, Sun Pharmaceutical) to the dynamic duo Restasis (cyclosporine ophthalmic emulsion 0.05%, Allergan) and Xiidra (lifitegrast ophthalmic solution 5%, Novartis) was
Uncategorized